Guillaume Lapointe

Novartis Institutes for BioMedical Research Basel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Larry Mark Fisher

Professor of Molecular Biology

St George’s, University of London

UNITED KINGDOM

View details

Klemens Kaupmann

Lab head

SWITZERLAND

View details

Mark R. Sanderson

Professor

St George’s, University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guillaume Lapointe

Research Interests

Explore related searches

Contact this professor

Articles (9)

Front Cover: [18F]NP3‐627, a Candidate PET Imaging Agent Targeting the NLRP3 Inflammasome in the Central Nervous System (ChemMedChem 4/2025)

[18F]NP3‐627, a Candidate PET Imaging Agent Targeting the NLRP3 Inflammasome in the Central Nervous System

Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors

Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches

MicroCycle: An Integrated and Automated Platform to Accelerate Drug Discovery

In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor

Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.

Metabolic phospholipid labeling of intact bacteria enables a fluorescence assay that detects compromised outer membranes.

Collaborators (3)

Larry Mark Fisher

Klemens Kaupmann

Mark R. Sanderson

Make your next move.